Migdal Insurance & Financial Holdings Ltd. boosted its stake in Mylan N.V. (NASDAQ:MYL) by 7.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,922,373 shares of the company’s stock after buying an additional 480,500 shares during the period. Mylan N.V. accounts for approximately 6.1% of Migdal Insurance & Financial Holdings Ltd.’s portfolio, making the stock its 2nd largest position. Migdal Insurance & Financial Holdings Ltd. owned 1.29% of Mylan N.V. worth $268,726,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of MYL. Swiss National Bank increased its stake in shares of Mylan N.V. by 3.1% during the second quarter. Swiss National Bank now owns 1,661,842 shares of the company’s stock valued at $64,513,000 after purchasing an additional 50,100 shares in the last quarter. Advisors Capital Management LLC increased its stake in shares of Mylan N.V. by 4.7% during the second quarter. Advisors Capital Management LLC now owns 86,329 shares of the company’s stock valued at $3,351,000 after purchasing an additional 3,854 shares in the last quarter. Vivaldi Asset Management LLC bought a new position in shares of Mylan N.V. during the second quarter valued at approximately $5,098,000. Mn Services Vermogensbeheer B.V. increased its stake in shares of Mylan N.V. by 508.8% during the second quarter. Mn Services Vermogensbeheer B.V. now owns 73,842 shares of the company’s stock valued at $2,867,000 after purchasing an additional 61,712 shares in the last quarter. Finally, Canada Pension Plan Investment Board increased its stake in shares of Mylan N.V. by 32.8% during the second quarter. Canada Pension Plan Investment Board now owns 610,319 shares of the company’s stock valued at $23,693,000 after purchasing an additional 150,906 shares in the last quarter. Institutional investors and hedge funds own 71.97% of the company’s stock.

Mylan N.V. (NASDAQ:MYL) traded up 0.98% on Friday, hitting $38.29. 6,284,973 shares of the company were exchanged. The firm’s 50 day moving average is $32.08 and its 200 day moving average is $36.45. The company has a market capitalization of $20.53 billion, a P/E ratio of 30.95 and a beta of 1.30. Mylan N.V. has a 52 week low of $29.39 and a 52 week high of $45.87. Mylan N.V. also was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 10,562 put options on the company. This represents an increase of approximately 461% compared to the average volume of 1,883 put options.

Mylan N.V. (NASDAQ:MYL) last released its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.18 by ($0.08). Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The business had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the previous year, the company earned $1.16 EPS. The firm’s revenue was up 15.7% compared to the same quarter last year. On average, equities research analysts forecast that Mylan N.V. will post $4.57 earnings per share for the current fiscal year.

A number of equities analysts have weighed in on MYL shares. Wells Fargo & Company set a $32.00 target price on shares of Mylan N.V. and gave the company a “hold” rating in a research note on Wednesday. Morgan Stanley raised their target price on shares of Mylan N.V. from $36.00 to $39.00 and gave the company an “equal weight” rating in a research note on Friday. Cantor Fitzgerald set a $34.00 target price on shares of Mylan N.V. and gave the company a “hold” rating in a research note on Wednesday, August 9th. ValuEngine downgraded shares of Mylan N.V. from a “buy” rating to a “hold” rating in a research note on Wednesday, June 14th. Finally, BMO Capital Markets reaffirmed a “buy” rating and set a $45.00 target price on shares of Mylan N.V. in a research note on Friday, September 29th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $41.99.

TRADEMARK VIOLATION WARNING: This piece was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/mylan-n-v-myl-shares-bought-by-migdal-insurance-financial-holdings-ltd/1615795.html.

Mylan N.V. Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan N.V. (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan N.V. (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.